Devices - DiabetesontheNet

Hybrid closed-loop technology and glycaemic outcomes according to baseline HbA1c

Benefits seen across the range of starting HbA_1c, whether high or low.

24 Mar 2022

Glycaemic control throughout the menstrual cycle in closed-loop technology users

Hybrid closed-loop system is effective throughout the menstrual cycle.

24 Mar 2022

Journal club: The need to reduce health inequality in accessing diabetes technology

Discussion of a recent notable paper. We review the effects of widespread flash glucose monitoring use in Scotland.

1 Mar 2022

CGM initiation within 1 year of diagnosis improves long-term glycaemic control

Initiating CGM early may set a better glycaemic trajectory, with effects on long-term diabetes outcomes.

15 Feb 2022

Delivering care at a distance for people with diabetes

Daniel Flanagan asks what is needed for diabetes services to successfully transition to a hybrid model of remote and face-to-face care.

24 Jan 2022

Remote care and insulin pump education: Current provision and healthcare professionals’ experience

Pump starts and renewals have been reduced in the pandemic as care delivery went primarily remote.

24 Jan 2022

Outcomes of funded CGM access in young people with type 1 diabetes in Australia

Universal funding of CGM results in rapid uptake and sustained use, as well as improvements in glycaemic control and clinical outcomes.

24 Jan 2022

Using CGM to predict progression to type 1 diabetes in children with positive islet autoantibodies

A cut-off of >10% of time above 7.8 mmol/L is an accurate predictor of progressing from islet autoimmunity to clinical type 1 diabetes.

24 Jan 2022

Accuracy and tolerability of alternative sites for flash glucose monitor sensor placement

Are the chest and the lower back clinically acceptable sites for flash glucose sensor placement?

24 Jan 2022

Latest news: NICE CGM update; what is the best diet for T2D; dapagliflozin T1D licence withdrawal; and JBDS VRIII audit

The latest news relevant to diabetes nursing: November–December 2021.

27 Dec 2021

Reducing ethnic inequalities in paediatric diabetes care: A Nottingham perspective

Improving insulin pump therapy access and average HbA1c in young people from minority ethnic backgrounds in Nottingham.

27 Dec 2021

NICE draft consultation recommends that all children and adults with type 1 diabetes have access to CGM

May Ng highlights why the proposed expansion in access to continuous and flash glucose monitoring is so important.

16 Dec 2021

Reducing ethnic inequalities in paediatric diabetes care: A Nottingham perspective

Improving insulin pump therapy access and average HbA_1c in young people from minority ethnic backgrounds in Nottingham.

16 Dec 2021

Using new technology to improve glucose control: The need to reduce health inequality

Daniel Flanagan asks whether current commissioning arrangements are leaving behind those who stand the most to gain.

3 Dec 2021

Effects of widespread flash glucose monitoring use in Scotland

HbA1c improves in those with poor control at initiation, and DKA and severe hypoglycaemia reduced overall.

3 Dec 2021

Continuing versus discontinuing CGM in people with type 2 diabetes

Discontinuing CGM results in a loss of nearly half of the improvements in time in range that are achieved during CGM use.

3 Dec 2021

Combining flash glucose monitoring with an automated bolus calculator

Does combining these two technologies improve HbA_1c?

3 Dec 2021

A prediction model for individual glycaemic responses to food

Using clinical, personal, dietary and even microbial data to predict an individual's postprandial glycaemic response.

29 Nov 2021